Streetbeat News

Analyst Ratings

ALHC

TD Cowen analyst Gary Taylor maintains a Buy rating on Alignment Healthcare (NASDAQ:ALHC) and raises the price target from $8 to $10.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 4:50 pm

INST

Baird analyst Joe Vruwink maintains a Neutral rating on Instructure Holdings (NYSE:INST) and raises the price target from $23 to $24.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 4:49 pm

BNTX

TD Cowen analyst Yaron Werber maintains a Hold rating on BioNTech (NASDAQ:BNTX) but lowers the price target from $98 to $85.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 4:48 pm

NEXA

Scotiabank analyst Orest Wowkodaw maintains a Sector Underperform rating on Nexa Resources (NYSE:NEXA) and lowers the price target from $7 to $6.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 4:48 pm

TBPH

TD Cowen analyst Marc Frahm maintains a Hold rating on Theravance Biopharma (NASDAQ:TBPH) and lowers the price target from $10 to $9.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 4:46 pm

MGA

Scotiabank analyst Jonathan Goldman maintains a Sector Perform rating on Magna International (NYSE:MGA) but lowers the price target from $52 to $50.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 4:45 pm

VFC

TD Cowen analyst John Kernan maintains a Hold rating on VF Corporation (NYSE:VFC) and raises the price target from $9 to $16.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 4:44 pm

SHOP

Shopify, Inc. (NYSE:SHOP) shares are moving higher ahead of its anticipated 2024 fiscal-year second quarter earnings release on Wednesday. Analysts estimate an EPS of 20 cents and revenue of $2.01 billion. The stock had previously traded lower in sympathy with Amazon's mixed earnings and soft guidance, and experienced a decline amid broader economic concerns. Currently, Shopify is trading 3.82% higher at $54.26.

Portfolio Pulse from Dylan Berman

August 06, 2024 | 4:44 pm

LNT

Scotiabank analyst Andrew Weisel maintains a Sector Outperform rating on Alliant Energy (NASDAQ:LNT) and raises the price target from $53 to $58.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 4:43 pm

BMRN

TD Cowen analyst Phil Nadeau maintains a Buy rating on Biomarin Pharmaceutical (NASDAQ:BMRN) but lowers the price target from $125 to $120.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 4:43 pm